IFF publishes 2025 annual report

Reuters03-18 21:30
IFF publishes 2025 annual report

IFF published its 2025 annual report, outlining a five-segment structure led by Taste, Food Ingredients, Health & Biosciences, and Scent, following the January 2025 split of the former Nourish segment into Taste and Food Ingredients. The report notes the divestiture of the Pharma Solutions business and the nitrocellulose business in May 2025 as part of portfolio changes. Reported 2025 net sales were USD 10.89 billion, down 5% year over year, while comparable currency neutral sales increased 2%. The company recorded a USD 1.15 billion goodwill impairment tied to the Food Ingredients reporting unit following the segment reorganization. IFF reported approximately 21,500 employees and about 170 manufacturing facilities, creative centers, and application laboratories across roughly 30 countries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IFF - International Flavors & Fragrances Inc. published the original content used to generate this news brief on March 18, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment